These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17174420)

  • 21. Renal dysfunction and anemia in patients with heart failure with reduced versus normal ejection fraction.
    Villacorta H; Saenz-Tello BF; Santos EB; Steffen R; Wiefels C; Lima LC; Sales AL; Soares P; Mesquita ET
    Arq Bras Cardiol; 2010 Mar; 94(3):357-63, 378-84. PubMed ID: 20730266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
    Komajda M; Anker SD; Charlesworth A; Okonko D; Metra M; Di Lenarda A; Remme W; Moullet C; Swedberg K; Cleland JG; Poole-Wilson PA
    Eur Heart J; 2006 Jun; 27(12):1440-6. PubMed ID: 16717081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of anaemia and kidney function in congestive heart failure and preserved systolic function.
    Philipp S; Ollmann H; Schink T; Dietz R; Luft FC; Willenbrock R
    Nephrol Dial Transplant; 2005 May; 20(5):915-9. PubMed ID: 15741202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction.
    Kajimoto K; Sato N; Takano T;
    Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):89-99. PubMed ID: 26124457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.
    Silverberg DS; Wexler D; Blum M; Keren G; Sheps D; Leibovitch E; Brosh D; Laniado S; Schwartz D; Yachnin T; Shapira I; Gavish D; Baruch R; Koifman B; Kaplan C; Steinbruch S; Iaina A
    J Am Coll Cardiol; 2000 Jun; 35(7):1737-44. PubMed ID: 10841219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, risk factors, and significance of iron deficiency and anemia in nonischemic heart failure patients with reduced ejection fraction from a Himachal Pradesh heart failure registry.
    Negi PC; Dev M; Paul P; Pal Singh D; Rathoure S; Kumar R; Dhiman A; Kandoria A; Ganju N; Sharma R; Bhardwaj R; Merwaha R; Asotra S; Mahajan K; Sondhi S; Rao S
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S182-S188. PubMed ID: 30595254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
    O'Meara E; Clayton T; McEntegart MB; McMurray JJ; Lang CC; Roger SD; Young JB; Solomon SD; Granger CB; Ostergren J; Olofsson B; Michelson EL; Pocock S; Yusuf S; Swedberg K; Pfeffer MA;
    Circulation; 2006 Feb; 113(7):986-94. PubMed ID: 16476847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence and significance of anaemia in patients with chronic congestive heart failure].
    Egelykke K; Petersen H; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1860-4. PubMed ID: 16756803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry.
    Waldum B; Westheim AS; Sandvik L; Flønæs B; Grundtvig M; Gullestad L; Hole T; Os I
    J Am Coll Cardiol; 2012 Jan; 59(4):371-8. PubMed ID: 22261159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.
    de Silva R; Rigby AS; Witte KK; Nikitin NP; Tin L; Goode K; Bhandari S; Clark AL; Cleland JG
    Am J Cardiol; 2006 Aug; 98(3):391-8. PubMed ID: 16860030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of anemia in cardiorenal disease.
    Anand IS
    Rev Cardiovasc Med; 2005; 6 Suppl 3():S13-21. PubMed ID: 16340934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis.
    Jones H; Talwar M; Nogueira JM; Ugarte R; Cangro C; Rasheed H; Klassen DK; Weir MR; Haririan A
    Transplantation; 2012 May; 93(9):923-8. PubMed ID: 22377790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiorenal anemia syndrome as a prognosticator for death in heart failure.
    Lu KJ; Kearney LG; Hare DL; Ord M; Toia D; Jones E; Burrell LM; Srivastava PM
    Am J Cardiol; 2013 Apr; 111(8):1187-91. PubMed ID: 23375730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey.
    Kleinert J; Dehout F; Schwarting A; de Lorenzo AG; Ricci R; Kampmann C; Beck M; Ramaswami U; Linhart A; Gal A; Houge G; Widmer U; Mehta A; Sunder-Plassmann G
    Kidney Int; 2005 May; 67(5):1955-60. PubMed ID: 15840043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
    Tang WH; Tong W; Jain A; Francis GS; Harris CM; Young JB
    J Am Coll Cardiol; 2008 Feb; 51(5):569-76. PubMed ID: 18237687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Impact of Anemia in Patients With Chronic Heart Failure- With Special Reference to Clinical Background: Report From the CHART-2 Study.
    Yamauchi T; Sakata Y; Takada T; Nochioka K; Miura M; Tadaki S; Ushigome R; Sato K; Onose T; Tsuji K; Abe R; Takahashi J; Miyata S; Shimokawa H;
    Circ J; 2015; 79(9):1984-93. PubMed ID: 26050711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
    Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease.
    Wali RK; Wang GS; Gottlieb SS; Bellumkonda L; Hansalia R; Ramos E; Drachenberg C; Papadimitriou J; Brisco MA; Blahut S; Fink JC; Fisher ML; Bartlett ST; Weir MR
    J Am Coll Cardiol; 2005 Apr; 45(7):1051-60. PubMed ID: 15808763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
    Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of anemia in Chinese nursing home older adults: implication of age and renal impairment.
    Chan TC; Yap DY; Shea YF; Luk JK; Chan FH; Chu LW
    Geriatr Gerontol Int; 2013 Jul; 13(3):591-6. PubMed ID: 22994890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.